Amgen Inc. Equity-NMS: AMGN

Healthcare

Drug Manufacturers-General

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$246.73
Today's low :$244.55
52W low :$198.64
52W high :$258.45
1Y :1.01%
5Y :43.43%
EPS(TTM): :10.12
Shares O/S :534.2 M
Market cap :131.01 B

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Amgen Inc. today?

Amgen Inc. (AMGN) share price as of July 6, 2022, is $0. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Amgen Inc.?

Yes, Indian Investors can invest in the Amgen Inc. (AMGN) Share by opening an international trading account with Angel One.

How can I purchase Amgen Inc. shares in India?

Purchasing Amgen Inc. (AMGN) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Amgen Inc. (AMGN) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Amgen Inc.?

Yes, you can purchase fractional shares of Amgen Inc. (AMGN) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Amgen Inc.?

The market capitalization of Amgen Inc. on July 6, 2022, is $131.33 B.

In which sector Amgen Inc. belongs?

Amgen Inc. operates in the Healthcare sector, specifically in the Drug Manufacturers-General industry.

What documents are required to invest in Amgen Inc. stocks?

In order to invest in Amgen Inc. (AMGN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Amgen Inc.

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.